Targeting Cyclin-Dependent Kinases in Ovarian Cancer
Author:
Affiliation:
1. Department of Obstetrics and Gynecology, The Affiliate Hospital of Guizhou Medical University, Guizhou, China
Publisher
Informa UK Limited
Subject
Cancer Research,Oncology,General Medicine
Link
https://www.tandfonline.com/doi/pdf/10.1080/07357907.2017.1283508
Reference86 articles.
1. Cancer statistics, 2015
2. New therapies for ovarian cancer: Cytotoxics and molecularly targeted agents
3. Diverse molecular pathways in ovarian cancer and their clinical significance
4. New perspectives in ovarian cancer treatment
5. Cyclin E1 and RTK/RAS signaling drive CDK inhibitor resistance via activation of E2F and ETS
Cited by 22 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. CANCER THERAPY BY CYCLIN-DEPENDENT KINASE INHIBITORS (CDKIS): BENCH TO BEDSIDE;EXCLI J;2024
2. RTA dh404 Induces Cell Cycle Arrest, Apoptosis, and Autophagy in Glioblastoma Cells;International Journal of Molecular Sciences;2023-02-16
3. Endometrial cancer prognosis prediction using correlation models based on CDK family genes;Frontiers in Genetics;2022-10-10
4. Heat Shock Protein 90 (HSP90) Inhibitors as Anticancer Medicines: A Review on the Computer-Aided Drug Discovery Approaches over the Past Five Years;Computational and Mathematical Methods in Medicine;2022-05-31
5. The Emerging Role of Cyclin-Dependent Kinase Inhibitors in Treating Diet-Induced Obesity: New Opportunities for Breast and Ovarian Cancers?;Cancers;2022-05-30
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3